Organigram Holdings Inc. Gross Profit

Gross Profit of OGI for past 10 years: annual, quarterly and twelve month trailing (TTM) including Gross Profit growth rates and interactive chart. Gross profit is a company's net sales revenue minus its cost of goods sold (or cost of revenue). In other words, it is the sales revenue a company retains after incurring the direct costs associated with producing the goods it sells, and the services it provides.


Highlights and Quick Summary

  • Gross Profit for the quarter ending November 30, 2022 was $17.7 Million (a 58.47% increase compared to previous quarter)
  • Year-over-year quarterly Gross Profit increased by 148.54%
  • Annual Gross Profit for 2022 was $24.8 Million (a -210.81% decrease from previous year)
  • Annual Gross Profit for 2021 was $-22.4 Million (a -46.7% decrease from previous year)
  • Annual Gross Profit for 2020 was $-42 Million (a -214.94% decrease from previous year)
  • Twelve month Gross Profit ending November 30, 2022 was $42.1 Million (a 69.47% increase compared to previous quarter)
  • Twelve month trailing Gross Profit increased by 269.77% year-over-year
Trailing Gross Profit for the last four month:
30 Nov '22 31 Aug '22 31 May '22 28 Feb '22
$42.1 Million $24.8 Million $15.7 Million $11.4 Million
Visit stockrow.com/OGI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Gross Profit of Organigram Holdings Inc.

Most recent Gross Profitof OGI including historical data for past 10 years.

Interactive Chart of Gross Profit of Organigram Holdings Inc.

Organigram Holdings Inc. Gross Profit for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $17.73 $11.19 $6.01 $7.13 $24.82
2021 $0.49 $2.07 $1.69 $-13.49 $-22.4
2020 $-12.66 $-23.12 $-35.93 $8.57 $-42.02
2019 $8.47 $-8.83 $-0.13 $5.97 $36.56
2018 $39.55 $2.52 $41.11
2017 $-1.84
2016 $3.84

Business Profile of Organigram Holdings Inc.

Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic